J2797 HCPCS Level II code: Injection, rolapitant, 0.5 mg

J2797 is the HCPCS code for “Injection, rolapitant, 0.5 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.

Official description

J2797

Injection, rolapitant, 0.5 mg

Short description: Inj., rolapitant, 0.5 mg

HCPCS · United States

Notes for J2797

As CMS prints them, with any note J2797 takes from the headings above it.

Note

  • CMS processing note 0127: PUBLICATION 100.2, CHAPTER 15, 50.1.

Medicare details

The indicators CMS publishes with J2797 in its October 2026 file. They describe Medicare’s handling, not another payer’s.

Medicare coverage
Special coverage instructions apply
Medicare pricing
Drugs
Type of service
Medical care; Lump sum purchase of DME, prosthetics, orthotics
BETOS category
Other drugs
Added
Jan 1, 2019

Where J2797 sits

  1. 1J codesDrugs administered other than orally
  2. 2Active code J2797Injection, rolapitant, 0.5 mg

Source and release

Data release
HCPCS Level II · October 2026
Effective date
Oct 1, 2026
Publisher
CMS

This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.

Frequently asked questions

What does HCPCS code J2797 mean?

J2797 is the HCPCS code for “Injection, rolapitant, 0.5 mg” in CMS’s HCPCS Level II October 2026 release.

Does Medicare cover J2797?

CMS lists J2797’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.

Which HCPCS Level II release does this page use?

It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.